Pay in 4 interest-free payments of $5.61 Learn more
Ships within 48 hours · Estimated delivery Aug 7 - Aug 12
The transition protocol from tirzepatide provides specific guidance for this switch
In Phase 3 studies, retatrutide has been given as a once-weekly injection, usually starting at 2mg once weekly before increasing gradually every four weeks
Your first course should use 1mg of the 3 mg vial (one third of the vial)
At 4mg, the phase 2 trial showed 17.1% average weight loss at 48 weeks, which exceeds the maximum dose of semaglutide (14.9%) in its own trial
Retatrutide could become the first obesity therapy to carry a secondary indication for liver fat management, which would dramatically expand its clinical relevance beyond weight loss alone
US$ 20.04
US$ 22.98
US$ 29.46
US$ 22.01
